An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a <scp>real‐world</scp> practice setting: A report from the Fenfluramine European Early Access Program

Abstract

The magnitude, consistency, and durability of the response to add-on fenfluramine is consistent across age groups in patients with Dravet syndrome.